<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37259156</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1750-1326</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>31</Day></PubDate></JournalIssue><Title>Molecular neurodegeneration</Title><ISOAbbreviation>Mol Neurodegener</ISOAbbreviation></Journal><ArticleTitle>Looking for answers far away from the soma-the (un)known axonal functions of TDP-43, and their contribution to early NMJ disruption in ALS.</ArticleTitle><Pagination><StartPage>35</StartPage><MedlinePgn>35</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">35</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13024-023-00623-6</ELocationID><Abstract><AbstractText>Axon degeneration and Neuromuscular Junction (NMJ) disruption are key pathologies in the fatal neurodegenerative disease Amyotrophic Lateral Sclerosis (ALS). Despite accumulating evidence that axons and NMJs are impacted at a very early stage of the disease, current knowledge about the mechanisms leading to their degeneration remains elusive. Cytoplasmic mislocalization and accumulation of the protein TDP-43 are considered key pathological hallmarks of ALS, as they occur in&#x2009;~&#x2009;97% of ALS patients, both sporadic and familial. Recent studies have identified pathological accumulation of TDP-43 in intramuscular nerves of muscle biopsies collected from pre-diagnosed, early symptomatic ALS patients. These findings suggest a gain of function for TDP-43 in axons, which might facilitate early NMJ disruption. In this review, we dissect the process leading to axonal TDP-43 accumulation and phosphorylation, discuss the known and hypothesized roles TDP-43 plays in healthy axons, and review possible mechanisms that connect TDP-43 pathology to the axon and NMJ degeneration in ALS.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Ionescu</LastName><ForeName>Ariel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Room 605, Ramat Aviv, 69978, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Altman</LastName><ForeName>Topaz</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Room 605, Ramat Aviv, 69978, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perlson</LastName><ForeName>Eran</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-6047-9613</Identifier><AffiliationInfo><Affiliation>Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Room 605, Ramat Aviv, 69978, Tel Aviv, Israel. eranpe@tauex.tau.ac.il.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sagol School of Neuroscience, Tel-Aviv University, Tel-Aviv, Israel. eranpe@tauex.tau.ac.il.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mol Neurodegener</MedlineTA><NlmUniqueID>101266600</NlmUniqueID><ISSNLinking>1750-1326</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001369" MajorTopicYN="N">Axons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="Y">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009469" MajorTopicYN="N">Neuromuscular Junction</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">Axon</Keyword><Keyword MajorTopicYN="N">Condensates</Keyword><Keyword MajorTopicYN="N">Local synthesis</Keyword><Keyword MajorTopicYN="N">Motor neuron</Keyword><Keyword MajorTopicYN="N">NMJ</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword></KeywordList><CoiStatement>The authors declare they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>1</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>31</Day><Hour>23</Hour><Minute>44</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37259156</ArticleId><ArticleId IdType="pmc">PMC10233987</ArticleId><ArticleId IdType="doi">10.1186/s13024-023-00623-6</ArticleId><ArticleId IdType="pii">10.1186/s13024-023-00623-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ou SH, Wu F, Harrich D, Garc&#xed;a-Mart&#xed;nez LF, Gaynor RB. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J Virol. 1995;69(6):3584&#x2013;96. doi: 10.1128/jvi.69.6.3584-3596.1995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.69.6.3584-3596.1995</ArticleId><ArticleId IdType="pmc">PMC189073</ArticleId><ArticleId IdType="pubmed">7745706</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E, et al. Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J. 2001;20(7):1774&#x2013;84. doi: 10.1093/emboj/20.7.1774.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/20.7.1774</ArticleId><ArticleId IdType="pmc">PMC145463</ArticleId><ArticleId IdType="pubmed">11285240</ArticleId></ArticleIdList></Reference><Reference><Citation>Ederle H, Dormann D. TDP-43 and FUS en route from the nucleus to the cytoplasm. FEBS Lett. 2017;591(11):1489&#x2013;1507. doi: 10.1002/1873-3468.12646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.12646</ArticleId><ArticleId IdType="pubmed">28380257</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E, Baralle FE. Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. Front Biosci. 2008;13:867&#x2013;78. doi: 10.2741/2727.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/2727</ArticleId><ArticleId IdType="pubmed">17981595</ArticleId></ArticleIdList></Reference><Reference><Citation>Sternburg EL, Gruijs da Silva LA, Dormann D. Post-translational modifications on RNA-binding proteins: accelerators, brakes, or passengers in neurodegeneration? Trends Biochem Sci. 2022;47:6&#x2013;22. doi: 10.1016/j.tibs.2021.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2021.07.004</ArticleId><ArticleId IdType="pubmed">34366183</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald KK, et al. TAR DNA-binding protein 43 (TDP-43) regulates stress granule dynamics via differential regulation of G3BP and TIA-1. Hum Mol Genet. 2011;20(7):1400&#x2013;10. doi: 10.1093/hmg/ddr021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr021</ArticleId><ArticleId IdType="pubmed">21257637</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanai Y, Dohmae N, Hirokawa N. Kinesin transports RNA: Isolation and characterization of an RNA-transporting granule. Neuron. 2004;43(4):513&#x2013;25. doi: 10.1016/j.neuron.2004.07.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.07.022</ArticleId><ArticleId IdType="pubmed">15312650</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, Chitta RK, High AA, Taylor JP. Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. J Proteome Res. 2010;9:1104&#x2013;1120. doi: 10.1021/pr901076y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr901076y</ArticleId><ArticleId IdType="pmc">PMC2897173</ArticleId><ArticleId IdType="pubmed">20020773</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling SC, Polymenidou M, Cleveland DW. Converging mechanisms in als and FTD: Disrupted RNA and protein homeostasis. Neuron. 2013;79(3):416&#x2013;38. doi: 10.1016/j.neuron.2013.07.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.033</ArticleId><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassel JA, Reitz AB. Ubiquilin-2 (UBQLN2) binds with high affinity to the C-terminal region of TDP-43 and modulates TDP-43 levels in H4 cells: Characterization of inhibition by nucleic acids and 4-aminoquinolines. Biochim Biophys Acta Proteins Proteom. 2013;1834(6):964&#x2013;71. doi: 10.1016/j.bbapap.2013.03.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbapap.2013.03.020</ArticleId><ArticleId IdType="pmc">PMC3960997</ArticleId><ArticleId IdType="pubmed">23541532</ArticleId></ArticleIdList></Reference><Reference><Citation>Fran&#xe7;ois-Moutal L, et al. Structural Insights Into TDP-43 and Effects of Post-translational Modifications. Front Mol Neurosci. 2019;12:301. doi: 10.3389/fnmol.2019.00301.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00301</ArticleId><ArticleId IdType="pmc">PMC6934062</ArticleId><ArticleId IdType="pubmed">31920533</ArticleId></ArticleIdList></Reference><Reference><Citation>Giambruno R, Grzybowska EA, Fawzi NL, Dormann D. Editorial: The Role of Protein Post-Translational Modifications in Protein-RNA Interactions and RNP Assemblies. Front Mol Biosci. 2022;8:831810. doi: 10.3389/fmolb.2021.831810.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2021.831810</ArticleId><ArticleId IdType="pmc">PMC8764229</ArticleId><ArticleId IdType="pubmed">35059438</ArticleId></ArticleIdList></Reference><Reference><Citation>Berning BA, Walker AK. The pathobiology of TDP-43 C-terminal fragments in ALS and FTLD. Front Neurosci. 2019;13:335. doi: 10.3389/fnins.2019.00335.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00335</ArticleId><ArticleId IdType="pmc">PMC6470282</ArticleId><ArticleId IdType="pubmed">31031584</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668&#x2013;1672. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Su XW, Broach JR, Connor JR, Gerhard GS, Simmons Z. Genetic heterogeneity of amyotrophic lateral sclerosis: Implications for clinical practice and research. Muscle Nerve. 2014;49(6):786&#x2013;803. doi: 10.1002/mus.24198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.24198</ArticleId><ArticleId IdType="pubmed">24488689</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351(3):602&#x2013;11. doi: 10.1016/j.bbrc.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Igaz LM, et al. Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Am J Pathol. 2008;173(1):182&#x2013;94. doi: 10.2353/ajpath.2008.080003.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2008.080003</ArticleId><ArticleId IdType="pmc">PMC2438296</ArticleId><ArticleId IdType="pubmed">18535185</ArticleId></ArticleIdList></Reference><Reference><Citation>Suk TR, Rousseaux MWC. The role of TDP-43 mislocalization in amyotrophic lateral sclerosis. Mol Neurodegener. 2020;15:1&#x2013;16. doi: 10.1186/s13024-020-00397-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00397-1</ArticleId><ArticleId IdType="pmc">PMC7429473</ArticleId><ArticleId IdType="pubmed">32799899</ArticleId></ArticleIdList></Reference><Reference><Citation>Altman T, et al. Axonal TDP-43 condensates drive neuromuscular junction disruption through inhibition of local synthesis of nuclear encoded mitochondrial proteins. 2021;12:1&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8617040</ArticleId><ArticleId IdType="pubmed">34824257</ArticleId></ArticleIdList></Reference><Reference><Citation>Briese M, et al. Loss of Tdp-43 disrupts the axonal transcriptome of motoneurons accompanied by impaired axonal translation and mitochondria function. Acta Neuropathol Commun. 2020;8:116. doi: 10.1186/s40478-020-00987-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-00987-6</ArticleId><ArticleId IdType="pmc">PMC7379803</ArticleId><ArticleId IdType="pubmed">32709255</ArticleId></ArticleIdList></Reference><Reference><Citation>Holt CE, Martin KC, Schuman EM. Local translation in neurons: visualization and function. Nat Struct Mol Biol. 2019;26(7):557&#x2013;566. doi: 10.1038/s41594-019-0263-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-019-0263-5</ArticleId><ArticleId IdType="pubmed">31270476</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Erauskin J, et al. ALS/FTD-Linked Mutation in FUS Suppresses Intra-axonal Protein Synthesis and Drives Disease Without Nuclear Loss-of-Function of FUS. Neuron. 2018;100:816&#x2013;830.e7. doi: 10.1016/j.neuron.2018.09.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.09.044</ArticleId><ArticleId IdType="pmc">PMC6277851</ArticleId><ArticleId IdType="pubmed">30344044</ArticleId></ArticleIdList></Reference><Reference><Citation>Ionescu A, et al. Targeting the Sigma-1 Receptor via Pridopidine Ameliorates Central Features of ALS Pathology in a SOD1 G93A Model. Cell Death Dis. 2019;10(3):210. doi: 10.1038/s41419-019-1451-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-019-1451-2</ArticleId><ArticleId IdType="pmc">PMC6397200</ArticleId><ArticleId IdType="pubmed">30824685</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilsland LG, et al. Deficits in axonal transport precede ALS symptoms in vivo. Proc Natl Acad Sci U S A. 2010;107:20523&#x2013;20528. doi: 10.1073/pnas.1006869107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1006869107</ArticleId><ArticleId IdType="pmc">PMC2996651</ArticleId><ArticleId IdType="pubmed">21059924</ArticleId></ArticleIdList></Reference><Reference><Citation>Riva N, et al. Phosphorylated TDP-43 aggregates in peripheral motor nerves of patients with amyotrophic lateral sclerosis. Brain. 2022;145:276&#x2013;284. doi: 10.1093/brain/awab285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab285</ArticleId><ArticleId IdType="pmc">PMC8967102</ArticleId><ArticleId IdType="pubmed">35076694</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurashige T, et al. TDP-43 Accumulation Within Intramuscular Nerve Bundles of Patients With Amyotrophic Lateral Sclerosis. JAMA Neurol. 2022;79:693&#x2013;701. doi: 10.1001/jamaneurol.2022.1113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2022.1113</ArticleId><ArticleId IdType="pmc">PMC9127711</ArticleId><ArticleId IdType="pubmed">35604654</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer LR, et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol. 2004;185:232&#x2013;240. doi: 10.1016/j.expneurol.2003.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2003.10.004</ArticleId><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Dadon-Nachum M, Melamed E, Offen D. The, &#x201c;Dying-Back&#x201d; Phenomenon of Motor Neurons in ALS. J Mol Neurosci. 2011;43:470&#x2013;477. doi: 10.1007/s12031-010-9467-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-010-9467-1</ArticleId><ArticleId IdType="pubmed">21057983</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, et al. Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol. 2009;117:137&#x2013;149. doi: 10.1007/s00401-008-0477-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0477-9</ArticleId><ArticleId IdType="pmc">PMC2693625</ArticleId><ArticleId IdType="pubmed">19125255</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol. 2013;74:20&#x2013;38. doi: 10.1002/ana.23937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23937</ArticleId><ArticleId IdType="pmc">PMC3785076</ArticleId><ArticleId IdType="pubmed">23686809</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, et al. TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord. Acta Neuropathol. 2014;128:423&#x2013;437. doi: 10.1007/s00401-014-1299-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1299-6</ArticleId><ArticleId IdType="pmc">PMC4384652</ArticleId><ArticleId IdType="pubmed">24916269</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Ludolph A, Thal DR, del Tredici K. Amyotrophic lateral sclerosis: Dash-like accumulation of phosphorylated TDP-43 in somatodendritic and axonal compartments of somatomotor neurons of the lower brainstem and spinal cord. Acta Neuropathol. 2010;120:67&#x2013;74. doi: 10.1007/s00401-010-0683-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-010-0683-0</ArticleId><ArticleId IdType="pubmed">20379728</ArticleId></ArticleIdList></Reference><Reference><Citation>Onozato T, et al. Axonal TDP-43 aggregates in sporadic amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol. 2016;42:561&#x2013;572. doi: 10.1111/nan.12310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12310</ArticleId><ArticleId IdType="pubmed">26819002</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovi&#x10d;i&#x10d; A, et al. Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS. Nat Neurosci. 2015;18(9):1226&#x2013;1229. doi: 10.1038/nn.4085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4085</ArticleId><ArticleId IdType="pmc">PMC4552077</ArticleId><ArticleId IdType="pubmed">26308983</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YC, et al. Interactions between ALS-linked FUS and nucleoporins are associated with defects in the nucleocytoplasmic transport pathway. Nat Neurosci. 2021;24(8):1077&#x2013;1088. doi: 10.1038/s41593-021-00859-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-00859-9</ArticleId><ArticleId IdType="pmc">PMC8832378</ArticleId><ArticleId IdType="pubmed">34059832</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou CC, et al. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. Nat Neurosci 2017;21:2 21, 228&#x2013;239 (2018)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5800968</ArticleId><ArticleId IdType="pubmed">29311743</ArticleId></ArticleIdList></Reference><Reference><Citation>Khosravi B, et al. Cytoplasmic poly-GA aggregates impair nuclear import of TDP-43 in C9orf72 ALS/FTLD. Hum Mol Genet. 2017;26:790&#x2013;800.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5409121</ArticleId><ArticleId IdType="pubmed">28040728</ArticleId></ArticleIdList></Reference><Reference><Citation>Doll SG, et al. Recognition of the TDP-43 nuclear localization signal by importin &#x3b1;1/&#x3b2;. Cell Rep. 2022;39:111007. doi: 10.1016/j.celrep.2022.111007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2022.111007</ArticleId><ArticleId IdType="pmc">PMC9290431</ArticleId><ArticleId IdType="pubmed">35767952</ArticleId></ArticleIdList></Reference><Reference><Citation>Doll SG, Cingolani G. Importin &#x3b1;/&#x3b2; and the tug of war to keep TDP-43 in solution: quo vadis? Bioessays. 2022;44(12):e2200181. doi: 10.1002/BIES.202200181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/BIES.202200181</ArticleId><ArticleId IdType="pmc">PMC9969346</ArticleId><ArticleId IdType="pubmed">36253101</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil B, et al. Nuclear import receptors are recruited by FG-nucleoporins to rescue hallmarks of TDP-43 proteinopathy. Mol Neurodegener. 2022;17(1):80. doi: 10.1186/s13024-022-00585-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-022-00585-1</ArticleId><ArticleId IdType="pmc">PMC9733332</ArticleId><ArticleId IdType="pubmed">36482422</ArticleId></ArticleIdList></Reference><Reference><Citation>Alami NH, et al. Axonal Transport of TDP-43 mRNA Granules Is Impaired by ALS-Causing Mutations. Neuron. 2014;81:536&#x2013;543. doi: 10.1016/j.neuron.2013.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.12.018</ArticleId><ArticleId IdType="pmc">PMC3939050</ArticleId><ArticleId IdType="pubmed">24507191</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallini C, Bassell GJ, Rossoll W. The ALS disease protein TDP-43 is actively transported in motor neuron axons and regulates axon outgrowth. Hum Mol Genet. 2012;21:3703&#x2013;3718. doi: 10.1093/hmg/dds205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds205</ArticleId><ArticleId IdType="pmc">PMC3406762</ArticleId><ArticleId IdType="pubmed">22641816</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao YC, et al. RNA Granules Hitchhike on Lysosomes for Long-Distance Transport, Using Annexin A11 as a Molecular Tether. Cell. 2019;179:147&#x2013;164.e20. doi: 10.1016/j.cell.2019.08.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.08.050</ArticleId><ArticleId IdType="pmc">PMC6890474</ArticleId><ArticleId IdType="pubmed">31539493</ArticleId></ArticleIdList></Reference><Reference><Citation>Porta S, et al. Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo. Nat Commun 2018;9:1 9, 1&#x2013;15 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6181940</ArticleId><ArticleId IdType="pubmed">30310141</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding X, et al. Spreading of TDP-43 pathology via pyramidal tract induces ALS-like phenotypes in TDP-43 transgenic mice. Acta Neuropathol Commun. 2021;9:1&#x2013;17. doi: 10.1186/s40478-020-01112-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-01112-3</ArticleId><ArticleId IdType="pmc">PMC7814549</ArticleId><ArticleId IdType="pubmed">33461623</ArticleId></ArticleIdList></Reference><Reference><Citation>Smethurst P, et al. In vitro prion-like behaviour of TDP-43 in ALS. Neurobiol Dis. 2016;96:236&#x2013;247. doi: 10.1016/j.nbd.2016.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2016.08.007</ArticleId><ArticleId IdType="pmc">PMC5113659</ArticleId><ArticleId IdType="pubmed">27590623</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka T, et al. Prion-like Properties of Pathological TDP-43 Aggregates from Diseased Brains. Cell Rep. 2013;4:124&#x2013;134. doi: 10.1016/j.celrep.2013.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.06.007</ArticleId><ArticleId IdType="pubmed">23831027</ArticleId></ArticleIdList></Reference><Reference><Citation>Iguchi Y, et al. Exosome secretion is a key pathway for clearance of pathological TDP-43. Brain. 2016;139:3187&#x2013;3201. doi: 10.1093/brain/aww237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww237</ArticleId><ArticleId IdType="pmc">PMC5840881</ArticleId><ArticleId IdType="pubmed">27679482</ArticleId></ArticleIdList></Reference><Reference><Citation>Feiler MS, et al. TDP-43 is intercellularly transmitted across axon terminals. J Cell Biol. 2015;211:897&#x2013;911. doi: 10.1083/jcb.201504057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201504057</ArticleId><ArticleId IdType="pmc">PMC4657165</ArticleId><ArticleId IdType="pubmed">26598621</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorar&#xfa; G, et al. TDP-43 in skeletal muscle of patients affected with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010;11(1&#x2013;2):240&#x2013;3. doi: 10.3109/17482960902810890.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960902810890</ArticleId><ArticleId IdType="pubmed">19306141</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori F, et al. Phosphorylated TDP-43 aggregates in skeletal and cardiac muscle are a marker of myogenic degeneration in amyotrophic lateral sclerosis and various conditions. Acta Neuropathol Commun. 2019;7(1):165. doi: 10.1186/s40478-019-0824-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0824-1</ArticleId><ArticleId IdType="pmc">PMC6816170</ArticleId><ArticleId IdType="pubmed">31661037</ArticleId></ArticleIdList></Reference><Reference><Citation>Ketterer C, Zeiger U, Budak MT, Rubinstein NA, Khurana TS. Identification of the neuromuscular junction transcriptome of extraocular muscle by laser capture microdissection. Invest Ophthalmol Vis Sci. 2010;51(9):4589&#x2013;99. doi: 10.1167/iovs.09-4893.</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.09-4893</ArticleId><ArticleId IdType="pmc">PMC2941174</ArticleId><ArticleId IdType="pubmed">20393109</ArticleId></ArticleIdList></Reference><Reference><Citation>Riemenschneider H, et al. Gel-like inclusions of C-terminal fragments of TDP-43 sequester stalled proteasomes in neurons. EMBO Rep. 2022;23(6):e53890. doi: 10.15252/embr.202153890.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.202153890</ArticleId><ArticleId IdType="pmc">PMC9171420</ArticleId><ArticleId IdType="pubmed">35438230</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu S, et al. Heat-shock chaperone HSPB1 regulates cytoplasmic TDP-43 phase separation and liquid-to-gel transition. Nat Cell Biol. 2022;24(9):1378&#x2013;1393. doi: 10.1038/s41556-022-00988-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-022-00988-8</ArticleId><ArticleId IdType="pmc">PMC9872726</ArticleId><ArticleId IdType="pubmed">36075972</ArticleId></ArticleIdList></Reference><Reference><Citation>Orme&#xf1;o F, et al. Chaperone Mediated Autophagy Degrades TDP-43 Protein and Is Affected by TDP-43 Aggregation. Front Mol Neurosci. 2020;13:19. doi: 10.3389/fnmol.2020.00019.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2020.00019</ArticleId><ArticleId IdType="pmc">PMC7040037</ArticleId><ArticleId IdType="pubmed">32132902</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel P, et al. Intra-axonal translation of Khsrp mRNA slows axon regeneration by destabilizing localized mRNAs. Nucleic Acids Res. 2022;50(10):5772&#x2013;5792. doi: 10.1093/nar/gkac337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkac337</ArticleId><ArticleId IdType="pmc">PMC9177972</ArticleId><ArticleId IdType="pubmed">35556128</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotem N, et al. ALS Along the Axons &#x2013; Expression of Coding and Noncoding RNA Differs in Axons of ALS models. Sci Rep. 2017;7:44500. doi: 10.1038/srep44500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep44500</ArticleId><ArticleId IdType="pmc">PMC5353576</ArticleId><ArticleId IdType="pubmed">28300211</ArticleId></ArticleIdList></Reference><Reference><Citation>Fazal R, et al. HDAC6 inhibition restores TDP-43 pathology and axonal transport defects in human motor neurons with TARDBP mutations. EMBO J. 2021;40:e106177. doi: 10.15252/embj.2020106177.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020106177</ArticleId><ArticleId IdType="pmc">PMC8013789</ArticleId><ArticleId IdType="pubmed">33694180</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen TJ, et al. An acetylation switch controls TDP-43 function and aggregation propensity. Nat Commun 2015;6:1 6, 1&#x2013;13 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4407365</ArticleId><ArticleId IdType="pubmed">25556531</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirie E, et al. S-nitrosylated TDP-43 triggers aggregation, cell-to-cell spread, and neurotoxicity in hiPSCs and in vivo models of ALS/FTD. Proc Natl Acad Sci U S A. 2021;118:e2021368118. doi: 10.1073/pnas.2021368118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2021368118</ArticleId><ArticleId IdType="pmc">PMC7980404</ArticleId><ArticleId IdType="pubmed">33692125</ArticleId></ArticleIdList></Reference><Reference><Citation>Eck RJ, Kraemer BC, Liachko NF. Regulation of TDP-43 phosphorylation in aging and disease. Geroscience. 2021;43:1605&#x2013;1614. doi: 10.1007/s11357-021-00383-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-021-00383-5</ArticleId><ArticleId IdType="pmc">PMC8492835</ArticleId><ArticleId IdType="pubmed">34032984</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E. Functional Significance of TDP-43 Mutations in Disease. Adv Genet. 2015;91:1&#x2013;53. doi: 10.1016/bs.adgen.2015.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.adgen.2015.07.001</ArticleId><ArticleId IdType="pubmed">26410029</ArticleId></ArticleIdList></Reference><Reference><Citation>Conicella AE, et al. TDP-43 &#x3b1;-helical structure tunes liquid&#x2013;liquid phase separation and function. Proc Natl Acad Sci U S A. 2020;117:5883&#x2013;5894. doi: 10.1073/pnas.1912055117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1912055117</ArticleId><ArticleId IdType="pmc">PMC7084079</ArticleId><ArticleId IdType="pubmed">32132204</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada SJ, et al. Cytoplasmic Mislocalization of TDP-43 Is Toxic to Neurons and Enhanced by a Mutation Associated with Familial Amyotrophic Lateral Sclerosis. J Neurosci. 2010;30:639&#x2013;649. doi: 10.1523/JNEUROSCI.4988-09.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4988-09.2010</ArticleId><ArticleId IdType="pmc">PMC2821110</ArticleId><ArticleId IdType="pubmed">20071528</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson BS, et al. TDP-43 Is Intrinsically Aggregation-prone, and Amyotrophic Lateral Sclerosis-linked Mutations Accelerate Aggregation and Increase Toxicity. J Biol Chem. 2009;284:20329&#x2013;20339. doi: 10.1074/jbc.M109.010264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.010264</ArticleId><ArticleId IdType="pmc">PMC2740458</ArticleId><ArticleId IdType="pubmed">19465477</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva LAG, et al. Disease-linked TDP-43 hyperphosphorylation suppresses TDP-43 condensation and aggregation. EMBO J. 2022;41:e108443. doi: 10.15252/embj.2021108443.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2021108443</ArticleId><ArticleId IdType="pmc">PMC9016352</ArticleId><ArticleId IdType="pubmed">35112738</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka T, et al. Phosphorylation of TAR DNA-binding protein of 43 kDa (TDP-43) by truncated casein kinase 1&#x3b4; triggers mislocalization and accumulation of TDP-43. J Biol Chem. 2016;291:5473&#x2013;5483. doi: 10.1074/jbc.M115.695379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.695379</ArticleId><ArticleId IdType="pmc">PMC4786690</ArticleId><ArticleId IdType="pubmed">26769969</ArticleId></ArticleIdList></Reference><Reference><Citation>Krach F, et al. Transcriptome&#x2013;pathology correlation identifies interplay between TDP-43 and the expression of its kinase CK1E in sporadic ALS. Acta Neuropathol. 2018;136:405&#x2013;423. doi: 10.1007/s00401-018-1870-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1870-7</ArticleId><ArticleId IdType="pmc">PMC6215775</ArticleId><ArticleId IdType="pubmed">29881994</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Gonz&#xe1;lez L, et al. Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1&#x3b4; kinase inhibitor treatment. Sci Rep 2020;10:1 10, 1&#x2013;12 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7064575</ArticleId><ArticleId IdType="pubmed">32157143</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng X, et al. CHMP2B regulates TDP-43 phosphorylation and cytotoxicity independent of autophagy via CK1. J Cell Biol 2021;221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8570292</ArticleId><ArticleId IdType="pubmed">34726688</ArticleId></ArticleIdList></Reference><Reference><Citation>Nozal V, et al. TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy. J Med Chem. 2022;65:1585&#x2013;1607. doi: 10.1021/acs.jmedchem.1c01942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.1c01942</ArticleId><ArticleId IdType="pubmed">34978799</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y, et al. Tau-tubulin kinase 1 phosphorylates TDP-43 at disease-relevant sites and exacerbates TDP-43 pathology. Neurobiol Dis. 2021;161:105548. doi: 10.1016/j.nbd.2021.105548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2021.105548</ArticleId><ArticleId IdType="pubmed">34752923</ArticleId></ArticleIdList></Reference><Reference><Citation>Liachko NF, et al. CDC7 inhibition blocks pathological TDP-43 phosphorylation and neurodegeneration. Ann Neurol. 2013;74:39&#x2013;52. doi: 10.1002/ana.23870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23870</ArticleId><ArticleId IdType="pmc">PMC3775949</ArticleId><ArticleId IdType="pubmed">23424178</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis SA, Gan KA, Dowell JA, Cairns NJ, Gitcho MA. TDP-43 expression influences amyloid&#x3b2; plaque deposition and tau aggregation. Neurobiol Dis. 2017;103:154&#x2013;162. doi: 10.1016/j.nbd.2017.04.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2017.04.012</ArticleId><ArticleId IdType="pmc">PMC5544914</ArticleId><ArticleId IdType="pubmed">28416393</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferri A, et al. Activity of protein phosphatase calcineurin is decreased in sporadic and familial amyotrophic lateral sclerosispatients. J Neurochem. 2004;90:1237&#x2013;1242. doi: 10.1111/j.1471-4159.2004.02588.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2004.02588.x</ArticleId><ArticleId IdType="pubmed">15312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Liachko NF, et al. The phosphatase calcineurin regulates pathological TDP-43 phosphorylation. Acta Neuropathol. 2016;132:545&#x2013;561. doi: 10.1007/s00401-016-1600-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1600-y</ArticleId><ArticleId IdType="pmc">PMC5026939</ArticleId><ArticleId IdType="pubmed">27473149</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu J, et al. Protein Phosphatase 1 dephosphorylates TDP-43 and suppresses its function in tau exon 10 inclusion. FEBS Lett. 2018;592:402&#x2013;410. doi: 10.1002/1873-3468.12976.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.12976</ArticleId><ArticleId IdType="pubmed">29334120</ArticleId></ArticleIdList></Reference><Reference><Citation>Maraschi AM, et al. SUMOylation Regulates TDP-43 Splicing Activity and Nucleocytoplasmic Distribution. Mol Neurobiol. 2021;58:5682&#x2013;5702. doi: 10.1007/s12035-021-02505-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02505-8</ArticleId><ArticleId IdType="pmc">PMC8599232</ArticleId><ArticleId IdType="pubmed">34390468</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahoo PK, et al. Axonal G3BP1 stress granule protein limits axonal mRNA translation and nerve regeneration. Nat Commun. 2018;9:1&#x2013;14. doi: 10.1038/s41467-018-05647-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-05647-x</ArticleId><ArticleId IdType="pmc">PMC6105716</ArticleId><ArticleId IdType="pubmed">30135423</ArticleId></ArticleIdList></Reference><Reference><Citation>Maday S, Twelvetrees AE, Moughamian AJ, Holzbaur ELF. Axonal Transport: Cargo-Specific Mechanisms of Motility and Regulation. Neuron. 2014;84:292&#x2013;309. doi: 10.1016/j.neuron.2014.10.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.10.019</ArticleId><ArticleId IdType="pmc">PMC4269290</ArticleId><ArticleId IdType="pubmed">25374356</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrington AW, Ginty DD. Long-distance retrograde neurotrophic factor signalling in neurons. Nat Rev Neurosci. 2013;14:177&#x2013;187. doi: 10.1038/nrn3253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3253</ArticleId><ArticleId IdType="pubmed">23422909</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxton WM, Hollenbeck PJ. The axonal transport of mitochondria. J Cell Sci. 2012;125(9):2095&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3656622</ArticleId><ArticleId IdType="pubmed">22619228</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal A, Drerup CM. Axonal Transport and Mitochondrial Function in Neurons. Front Cell Neurosci. 2019;13:373. doi: 10.3389/fncel.2019.00373.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00373</ArticleId><ArticleId IdType="pmc">PMC6696875</ArticleId><ArticleId IdType="pubmed">31447650</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalla Costa I, et al. The functional organization of axonal mRNA transport and translation. Nat Rev Neurosci. 2021;22(2):77&#x2013;91. doi: 10.1038/s41583-020-00407-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-020-00407-7</ArticleId><ArticleId IdType="pmc">PMC8161363</ArticleId><ArticleId IdType="pubmed">33288912</ArticleId></ArticleIdList></Reference><Reference><Citation>Villarin JM, McCurdy EP, Mart&#xed;nez JC, Hengst U. Local synthesis of dynein cofactors matches retrograde transport to acutely changing demands. Nat Commun. 2016;7:13865. doi: 10.1038/ncomms13865.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms13865</ArticleId><ArticleId IdType="pmc">PMC5187584</ArticleId><ArticleId IdType="pubmed">28000671</ArticleId></ArticleIdList></Reference><Reference><Citation>Hafner AS, Donlin-Asp PG, Leitch B, Herzog E, Schuman EM. Local protein synthesis is a ubiquitous feature of neuronal pre- And postsynaptic compartments. Science (1979) 364, (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31097639</ArticleId></ArticleIdList></Reference><Reference><Citation>Kislauskis EH, Zhu X, Singer RH. beta-Actin messenger RNA localization and protein synthesis augment cell motility. J Cell Biol. 1997;136:1263&#x2013;1270. doi: 10.1083/jcb.136.6.1263.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.136.6.1263</ArticleId><ArticleId IdType="pmc">PMC2132521</ArticleId><ArticleId IdType="pubmed">9087442</ArticleId></ArticleIdList></Reference><Reference><Citation>Eng H, Lund K, Campenot RB. Synthesis of &#x3b2;-tubulin, actin, and other proteins in axons of sympathetic neurons in compartmented cultures. J Neurosci. 1999;19(1):1&#x2013;9. doi: 10.1523/JNEUROSCI.19-01-00001.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.19-01-00001.1999</ArticleId><ArticleId IdType="pmc">PMC6782370</ArticleId><ArticleId IdType="pubmed">9870932</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing L, Bassell GJ. mRNA localization: an orchestration of assembly, traffic and synthesis. Traffic. 2013;14:2&#x2013;14. doi: 10.1111/tra.12004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tra.12004</ArticleId><ArticleId IdType="pmc">PMC3548013</ArticleId><ArticleId IdType="pubmed">22913533</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiebler MA, Bassell GJ. Neuronal RNA Granules: Movers and Makers. Neuron. 2006;51(6):685&#x2013;90. doi: 10.1016/j.neuron.2006.08.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2006.08.021</ArticleId><ArticleId IdType="pubmed">16982415</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukavsky PJ, et al. Molecular basis of UG-rich RNA recognition by the human splicing factor TDP-43. Nat Struct Mol Biol. 2013;20(12):1443&#x2013;9. doi: 10.1038/nsmb.2698.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2698</ArticleId><ArticleId IdType="pubmed">24240615</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombrita C, et al. TDP-43 is recruited to stress granules in conditions of oxidative insult. J Neurochem. 2009;111(4):1051&#x2013;61. doi: 10.1111/j.1471-4159.2009.06383.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.06383.x</ArticleId><ArticleId IdType="pubmed">19765185</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang I-F, Wu L-S, Chang H-Y, Shen C-KJ. TDP-43, the signature protein of FTLD-U, is a neuronal activity-responsive factor. J Neurochem. 2008;105:797&#x2013;806. doi: 10.1111/j.1471-4159.2007.05190.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2007.05190.x</ArticleId><ArticleId IdType="pubmed">18088371</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z, et al. Neurodegeneration-associated TDP-43 interacts with fragile X mental retardation protein (FMRP)/staufen (STAU1) and regulates SIRT1 expression in neuronal cells. J Biol Chemi. 2012;287(27):22560&#x2013;72. doi: 10.1074/jbc.M112.357582.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.357582</ArticleId><ArticleId IdType="pmc">PMC3391095</ArticleId><ArticleId IdType="pubmed">22584570</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayanan RK, et al. Identification of RNA bound to the TDP-43 ribonucleoprotein complex in the adult mouse brain. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(4):252&#x2013;60. doi: 10.3109/21678421.2012.734520.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2012.734520</ArticleId><ArticleId IdType="pubmed">23134510</ArticleId></ArticleIdList></Reference><Reference><Citation>Sephton CF, et al. Identification of neuronal RNA targets of TDP-43-containing ribonucleoprotein complexes. J Biol Chem. 2011;286(2):1204&#x2013;15. doi: 10.1074/jbc.M110.190884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.190884</ArticleId><ArticleId IdType="pmc">PMC3020728</ArticleId><ArticleId IdType="pubmed">21051541</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala YM, et al. TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J. 2011;30(2):277&#x2013;88. doi: 10.1038/emboj.2010.310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2010.310</ArticleId><ArticleId IdType="pmc">PMC3025456</ArticleId><ArticleId IdType="pubmed">21131904</ArticleId></ArticleIdList></Reference><Reference><Citation>Harbauer AB, et al. Neuronal mitochondria transport Pink1 mRNA via synaptojanin 2 to support local mitophagy. Neuron. 2022;110(9):1516&#x2013;1531.e9. doi: 10.1016/j.neuron.2022.01.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.01.035</ArticleId><ArticleId IdType="pmc">PMC9081165</ArticleId><ArticleId IdType="pubmed">35216662</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen B, et al. Co-transport of the nuclear-encoded Cox7c mRNA with mitochondria along axons occurs through a coding-region-dependent mechanism. J Cell Sci. 2022;135:jcs259436. doi: 10.1242/jcs.259436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.259436</ArticleId><ArticleId IdType="pmc">PMC9481926</ArticleId><ArticleId IdType="pubmed">35833493</ArticleId></ArticleIdList></Reference><Reference><Citation>Cioni J-M, et al. Late Endosomes Act as mRNA Translation Platforms and Sustain Mitochondria in Axons Article Late Endosomes Act as mRNA Translation Platforms and Sustain Mitochondria in Axons. Cell. 2019;176:56&#x2013;72. doi: 10.1016/j.cell.2018.11.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.11.030</ArticleId><ArticleId IdType="pmc">PMC6333918</ArticleId><ArticleId IdType="pubmed">30612743</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, et al. The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity. Nat Med. 2016;22(8):869&#x2013;78. doi: 10.1038/nm.4130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4130</ArticleId><ArticleId IdType="pmc">PMC4974139</ArticleId><ArticleId IdType="pubmed">27348499</ArticleId></ArticleIdList></Reference><Reference><Citation>Magran&#xe9; J, Cortez C, Gan WB, Manfredi G. Abnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models. Hum Mol Genet. 2014;23(6):1413&#x2013;24. doi: 10.1093/hmg/ddt528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt528</ArticleId><ArticleId IdType="pmc">PMC3929084</ArticleId><ArticleId IdType="pubmed">24154542</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P, et al. TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response. PLoS Genet. 2019;15(5):e1007947. doi: 10.1371/journal.pgen.1007947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1007947</ArticleId><ArticleId IdType="pmc">PMC6524796</ArticleId><ArticleId IdType="pubmed">31100073</ArticleId></ArticleIdList></Reference><Reference><Citation>Terenzio M, et al. Locally translated mTOR controls axonal local translation in nerve injury. Science. 2018;1979(359):1416&#x2013;1421. doi: 10.1126/science.aan1053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aan1053</ArticleId><ArticleId IdType="pmc">PMC6501578</ArticleId><ArticleId IdType="pubmed">29567716</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosker KE, Pazyra-Murphy MF, Fenstermacher SJ, Segal RA. Target-derived neurotrophins coordinate transcription and transport of Bclw to prevent axonal degeneration. Ann Intern Med 2013;158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3866501</ArticleId><ArticleId IdType="pubmed">23516285</ArticleId></ArticleIdList></Reference><Reference><Citation>Lautenschl&#xe4;ger J. Protein phase separation hotspots at the presynapse. Open Biology. 2022;12(2):210334. doi: 10.1098/rsob.210334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsob.210334</ArticleId><ArticleId IdType="pmc">PMC8826138</ArticleId><ArticleId IdType="pubmed">35135293</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Wu X, Wu H, Zhang M. Phase separation at the synapse. Nat Neurosci. 2020;23(3):301&#x2013;310. doi: 10.1038/s41593-019-0579-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0579-9</ArticleId><ArticleId IdType="pubmed">32015539</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsang B, et al. Phosphoregulated FMRP phase separation models activity-dependent translation through bidirectional control of mRNA granule formation. Proc Natl Acad Sci U S A. 2019;116(10):4218&#x2013;4227. doi: 10.1073/pnas.1814385116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1814385116</ArticleId><ArticleId IdType="pmc">PMC6410804</ArticleId><ArticleId IdType="pubmed">30765518</ArticleId></ArticleIdList></Reference><Reference><Citation>So E, et al. Mitochondrial abnormalities and disruption of the neuromuscular junction precede the clinical phenotype and motor neuron loss in hFUSWT transgenic mice. Hum Mol Genet. 2018;27:463&#x2013;474. doi: 10.1093/hmg/ddx415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx415</ArticleId><ArticleId IdType="pmc">PMC5886082</ArticleId><ArticleId IdType="pubmed">29194538</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopal PP, Nirschl JJ, Klinman E, Holzbaurb ELF. Amyotrophic lateral sclerosis-linked mutations increase the viscosity of liquid-like TDP-43 RNP granules in neurons. Proc Natl Acad Sci U S A. 2017;114:E2466&#x2013;E2475. doi: 10.1073/pnas.1614462114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1614462114</ArticleId><ArticleId IdType="pmc">PMC5373408</ArticleId><ArticleId IdType="pubmed">28265061</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu-Yesucevitz L, et al. Tar DNA binding protein-43 (TDP-43) associates with stress granules: Analysis of cultured cells and pathological brain tissue. PLoS One. 2010;5(10):e13250. doi: 10.1371/journal.pone.0013250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0013250</ArticleId><ArticleId IdType="pmc">PMC2952586</ArticleId><ArticleId IdType="pubmed">20948999</ArticleId></ArticleIdList></Reference><Reference><Citation>Aulas A, Stabile S, Vande Velde C. Endogenous TDP-43, but not FUS, contributes to stress granule assembly via G3BP. Mol Neurodegener. 2012;7:54. doi: 10.1186/1750-1326-7-54.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-7-54</ArticleId><ArticleId IdType="pmc">PMC3502460</ArticleId><ArticleId IdType="pubmed">23092511</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo A, et al. Increased cytoplasmic TDP-43 reduces global protein synthesis by interacting with Rack1 on polyribosomes. Hum Mol Genet. 2017;26:1407&#x2013;1418. doi: 10.1093/hmg/ddx035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx035</ArticleId><ArticleId IdType="pmc">PMC6075552</ArticleId><ArticleId IdType="pubmed">28158562</ArticleId></ArticleIdList></Reference><Reference><Citation>Neelagandan N, et al. TDP-43 enhances translation of specific mRNAs linked to neurodegenerative disease. Nucleic Acids Res. 2019;47(1):341&#x2013;361. doi: 10.1093/nar/gky972.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky972</ArticleId><ArticleId IdType="pmc">PMC6326785</ArticleId><ArticleId IdType="pubmed">30357366</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne AN, et al. Fragile X protein mitigates TDP-43 toxicity by remodeling RNA granules and restoring translation. Hum Mol Genet. 2015;24(24):6886&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5007633</ArticleId><ArticleId IdType="pubmed">26385636</ArticleId></ArticleIdList></Reference><Reference><Citation>Gioio AE, et al. Local synthesis of nuclear-encoded mitochondrial proteins in the presynaptic nerve terminal. J Neurosci Res. 2001;64(5):447&#x2013;53. doi: 10.1002/jnr.1096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.1096</ArticleId><ArticleId IdType="pubmed">11391699</ArticleId></ArticleIdList></Reference><Reference><Citation>Hillefors M, Gioio AE, Mameza MG, Kaplan BB. Axon viability and mitochondrial function are dependent on local protein synthesis in sympathetic neurons. Cell Mol Neurobiol. 2007;27(6):701&#x2013;16. doi: 10.1007/s10571-007-9148-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-007-9148-y</ArticleId><ArticleId IdType="pubmed">17619140</ArticleId></ArticleIdList></Reference><Reference><Citation>Maciel R, et al. The human motor neuron axonal transcriptome is enriched for transcripts related to mitochondrial function and microtubule-based axonal transport. Exp Neurol. 2018;307:155&#x2013;163. doi: 10.1016/j.expneurol.2018.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2018.06.008</ArticleId><ArticleId IdType="pmc">PMC6713456</ArticleId><ArticleId IdType="pubmed">29935168</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, et al. The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons. Hum Mol Genet. 2013;22(23):4706&#x2013;19. doi: 10.1093/hmg/ddt319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt319</ArticleId><ArticleId IdType="pmc">PMC3820133</ArticleId><ArticleId IdType="pubmed">23827948</ArticleId></ArticleIdList></Reference><Reference><Citation>Shigeoka T, et al. On-Site Ribosome Remodeling by Locally Synthesized Ribosomal Proteins in Axons. Cell Rep. 2019;29(11):3605&#x2013;3619.e10. doi: 10.1016/j.celrep.2019.11.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.11.025</ArticleId><ArticleId IdType="pmc">PMC6915326</ArticleId><ArticleId IdType="pubmed">31825839</ArticleId></ArticleIdList></Reference><Reference><Citation>von K&#xfc;gelgen N, Chekulaeva M. Conservation of a core neurite transcriptome across neuronal types and species. Wiley Interdiscip Rev: RNA. 2020;11(4):e1590. doi: 10.1002/wrna.1590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wrna.1590</ArticleId><ArticleId IdType="pubmed">32059075</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagano S, et al. TDP-43 transports ribosomal protein mRNA to regulate axonal local translation in neuronal axons. Acta Neuropathol. 2020;1:3.</Citation><ArticleIdList><ArticleId IdType="pubmed">32803350</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartel DP. Metazoan MicroRNAs. Cell. 2018;173(1):20&#x2013;51. doi: 10.1016/j.cell.2018.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.006</ArticleId><ArticleId IdType="pmc">PMC6091663</ArticleId><ArticleId IdType="pubmed">29570994</ArticleId></ArticleIdList></Reference><Reference><Citation>Gershoni-Emek N, et al. Localization of RNAi Machinery to Axonal Branch Points and Growth Cones Is Facilitated by Mitochondria and Is Disrupted in ALS. Front Mol Neurosci. 2018;11:311. doi: 10.3389/fnmol.2018.00311.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00311</ArticleId><ArticleId IdType="pmc">PMC6134038</ArticleId><ArticleId IdType="pubmed">30233312</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki Y, Gross C, Xing L, Goshima Y, Bassell GJ. Identification of axon-enriched MicroRNAs localized to growth cones of cortical neurons. Dev Neurobiol. 2013. 10.1002/dneu.22113</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4111797</ArticleId><ArticleId IdType="pubmed">23897634</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreassi C, et al. Cytoplasmic cleavage of IMPA1 3&#x2032; UTR is necessary for maintaining axon integrity. Cell Rep. 2021;34(8):108778. doi: 10.1016/j.celrep.2021.108778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.108778</ArticleId><ArticleId IdType="pmc">PMC7918530</ArticleId><ArticleId IdType="pubmed">33626357</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, Bao L. Axonal microRNAs: Localization, function and regulatory mechanism during axon development. J Mol Cell Biol. 2017;9(2):82&#x2013;90. doi: 10.1093/jmcb/mjw050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jmcb/mjw050</ArticleId><ArticleId IdType="pmc">PMC5439374</ArticleId><ArticleId IdType="pubmed">27932485</ArticleId></ArticleIdList></Reference><Reference><Citation>Corradi E, Baudet ML. In the right place at the right time: Mirnas as key regulators in developing axons. Int J Mol Sci. 2020;21(22):8726. doi: 10.3390/ijms21228726.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21228726</ArticleId><ArticleId IdType="pmc">PMC7699167</ArticleId><ArticleId IdType="pubmed">33218218</ArticleId></ArticleIdList></Reference><Reference><Citation>Corradi E, et al. Axonal precursor mi RNA s hitchhike on endosomes&#xa0;and locally regulate the development of neural circuits. EMBO J. 2020;39(6):e102513. doi: 10.15252/embj.2019102513.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2019102513</ArticleId><ArticleId IdType="pmc">PMC7073465</ArticleId><ArticleId IdType="pubmed">32073171</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawahara Y, Mieda-Sato A. TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes. Proc Natl Acad Sci U S A. 2012;109(9):3347&#x2013;52. doi: 10.1073/pnas.1112427109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1112427109</ArticleId><ArticleId IdType="pmc">PMC3295278</ArticleId><ArticleId IdType="pubmed">22323604</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E, et al. Nuclear factor TDP-43 can affect selected microRNA levels. FEBS J. 2010;277(10):2268&#x2013;81. doi: 10.1111/j.1742-4658.2010.07643.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2010.07643.x</ArticleId><ArticleId IdType="pubmed">20423455</ArticleId></ArticleIdList></Reference><Reference><Citation>Paez-Colasante X, et al. Cytoplasmic TDP43 Binds microRNAs: New Disease Targets in Amyotrophic Lateral Sclerosis. Front Cell Neurosci. 2020;14:117. doi: 10.3389/fncel.2020.00117.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.00117</ArticleId><ArticleId IdType="pmc">PMC7235295</ArticleId><ArticleId IdType="pubmed">32477070</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung AKL, Calabrese JM, Sharp PA. Quantitative analysis of argonaute protein reveals microRNA-dependent localization to stress granules. Proc Natl Acad Sci U S A. 2006;103(48):18125&#x2013;30. doi: 10.1073/pnas.0608845103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0608845103</ArticleId><ArticleId IdType="pmc">PMC1838717</ArticleId><ArticleId IdType="pubmed">17116888</ArticleId></ArticleIdList></Reference><Reference><Citation>Pare JM, et al. Hsp90 regulates the function of argonaute 2 and its recruitment to stress granules and P-bodies. Mol Biol Cell. 2009;20(14):3273&#x2013;84. doi: 10.1091/mbc.e09-01-0082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e09-01-0082</ArticleId><ArticleId IdType="pmc">PMC2710822</ArticleId><ArticleId IdType="pubmed">19458189</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo X, et al. TDP-43 aggregation induced by oxidative stress causes global mitochondrial imbalance in ALS. Nat Struct Mol Biol. 2021;28(2):132&#x2013;142. doi: 10.1038/s41594-020-00537-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-020-00537-7</ArticleId><ArticleId IdType="pubmed">33398173</ArticleId></ArticleIdList></Reference><Reference><Citation>Sleigh JN, et al. Mice Carrying ALS Mutant TDP-43, but Not Mutant FUS, Display In Vivo Defects in Axonal Transport of Signaling Endosomes. Cell Rep. 2020;30:3655&#x2013;3662.e2. doi: 10.1016/j.celrep.2020.02.078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.02.078</ArticleId><ArticleId IdType="pmc">PMC7090381</ArticleId><ArticleId IdType="pubmed">32187538</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Cohen TJ. Aggregation of the nucleic acid&#x2013; binding protein TDP-43 occurs via distinct routes that are coordinated with stress granule formation. J Biol Chem. 2019;294:3696&#x2013;3706. doi: 10.1074/jbc.RA118.006351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.006351</ArticleId><ArticleId IdType="pmc">PMC6416430</ArticleId><ArticleId IdType="pubmed">30630951</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling JP, Pletnikova O, Troncoso JC, Wong PC. TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD. Science. 2015;1979(349):650&#x2013;655. doi: 10.1126/science.aab0983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aab0983</ArticleId><ArticleId IdType="pmc">PMC4825810</ArticleId><ArticleId IdType="pubmed">26250685</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma XR, et al. TDP-43 represses cryptic exon inclusion in the FTD&#x2013;ALS gene UNC13A. Nature. 2022;603(7899):124&#x2013;130. doi: 10.1038/s41586-022-04424-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04424-7</ArticleId><ArticleId IdType="pmc">PMC8891019</ArticleId><ArticleId IdType="pubmed">35197626</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook C, Petrucelli L. Genetic Convergence Brings Clarity to the Enigmatic Red Line in ALS. Neuron. 2019;101:1057&#x2013;1069. doi: 10.1016/j.neuron.2019.02.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.02.032</ArticleId><ArticleId IdType="pubmed">30897357</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathieu C, Pappu RV, Taylor JP. Beyond aggregation: Pathological phase transitions in neurodegenerative disease. Science (1979) 370, (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8359821</ArticleId><ArticleId IdType="pubmed">33004511</ArticleId></ArticleIdList></Reference><Reference><Citation>Portz B, Lee BL, Shorter J. FUS and TDP-43 Phases in Health and Disease. Trends Biochem Sci. 2021;46:550&#x2013;563. doi: 10.1016/j.tibs.2020.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2020.12.005</ArticleId><ArticleId IdType="pmc">PMC8195841</ArticleId><ArticleId IdType="pubmed">33446423</ArticleId></ArticleIdList></Reference><Reference><Citation>Molliex A, et al. Phase Separation by Low Complexity Domains Promotes Stress Granule Assembly and Drives Pathological Fibrillization. Cell. 2015;163:123&#x2013;133. doi: 10.1016/j.cell.2015.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.09.015</ArticleId><ArticleId IdType="pmc">PMC5149108</ArticleId><ArticleId IdType="pubmed">26406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann JR, et al. RNA Binding Antagonizes Neurotoxic Phase Transitions of TDP-43. Neuron. 2019;102:321&#x2013;338.e8. doi: 10.1016/j.neuron.2019.01.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.01.048</ArticleId><ArticleId IdType="pmc">PMC6472983</ArticleId><ArticleId IdType="pubmed">30826182</ArticleId></ArticleIdList></Reference><Reference><Citation>Conicella AE, Zerze GH, Mittal J, Fawzi NL. ALS Mutations Disrupt Phase Separation Mediated by &#x3b1;-Helical Structure in the TDP-43 Low-Complexity C-Terminal Domain. Structure. 2016;24:1537&#x2013;1549. doi: 10.1016/j.str.2016.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2016.07.007</ArticleId><ArticleId IdType="pmc">PMC5014597</ArticleId><ArticleId IdType="pubmed">27545621</ArticleId></ArticleIdList></Reference><Reference><Citation>McGurk L, et al. Poly(ADP-Ribose) Prevents Pathological Phase Separation of TDP-43 by Promoting Liquid Demixing and Stress Granule Localization. Mol Cell. 2018;71:703&#x2013;717.e9. doi: 10.1016/j.molcel.2018.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.07.002</ArticleId><ArticleId IdType="pmc">PMC6128762</ArticleId><ArticleId IdType="pubmed">30100264</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, et al. In vivo stress granule misprocessing evidenced in a FUS knock-in ALS mouse model. Brain. 2020;143:1350&#x2013;1367. doi: 10.1093/brain/awaa076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa076</ArticleId><ArticleId IdType="pubmed">32358598</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubinski A, et al. Stress granule assembly in vivo is deficient in the CNS of mutant TDP-43 ALS mice. Hum Mol Genet.2022 10.1093/HMG/DDAC206</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9840205</ArticleId><ArticleId IdType="pubmed">35994036</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E. Targeting TDP-43 proteinopathy with drugs and drug-like small molecules. British Journal of Pharmacology. 2021;178(6):1298&#x2013;1315. doi: 10.1111/bph.15148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15148</ArticleId><ArticleId IdType="pubmed">32469420</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>